Today's Markets 5-Minute Digest (2026.07.21)
Earnings season is delivering upside surprises from GM and Charles Schwab even as the AI trade stays choppy, with chip names bouncing after a recent slide. Overshadowing it all is renewed US-Iran conflict that is keeping oil elevated and putting inflation back in focus, while fresh Trump tariffs on Canadian goods and a Jamie Dimon caution add to the crosscurrents.
1. GM raises full-year guidance; Schwab profits surge; AMC posts record revenue

General Motors beat on second-quarter earnings and raised its full-year guidance, citing a 'resilient' consumer, pricing and lower costs, with revenue growing for the first time in over a year. GM's stock bounced back on the results, and reporting flagged GM among the day's lead earnings movers alongside 3M.
Charles Schwab reported a profit surge as retail traders bought the dip during a volatile quarter, beating estimates ahead of Interactive Brokers' results. Separately, AMC Entertainment posted record revenue, raising the question of whether the theater recovery is taking hold.
- GM beats on earnings, raises guidance amid 'resilient' consumer, pricing
- GM's stock bounces back as revenue grows for the first time in over a year
- Charles Schwab profits surge as retail traders bought the dip in a volatile quarter
2. Chip stocks rebound; Nvidia takes 9.3% Nebius stake ahead of Alphabet earnings

Chip stocks led futures higher, with Sandisk, Micron and AMD jumping as the AI trade rebounded after a recent slide, and world shares mostly gained as South Korea and Japan recovered some AI-driven losses. Nebius stock surged after Nvidia disclosed a 9.3% stake in the neocloud company.
The rebound comes amid ongoing debate over the AI trade. Alphabet is set to report Q2 earnings, described as a test of whether its record data-center spending is paying off, while Morgan Stanley cut Adobe to underweight amid AI fears and Jim Cramer suggested looking beyond tech given AI uncertainty.
- Nebius stock surges as Nvidia discloses 9.3% stake in neocloud
- Stock Market Today: Sandisk, Micron, AMD Jump As AI Rebounds; GM, 3M Lead Earnings Movers
- Google parent Alphabet to report Q2 earnings in latest test of AI trade
3. US-Iran conflict keeps oil elevated, reviving inflation fears; yields little changed

The U.S. struck Iran and Houthis threatened Saudi Arabia shipping as mediators pushed a 10-day ceasefire, keeping oil prices firm as investors weighed fresh attacks against ceasefire prospects. Analysts said inflation fears are back in the spotlight as the conflict keeps oil prices high, with CNBC outlining parts of the market and economy that could be affected.
Treasury yields were little changed as investors mapped geopolitical risks, and the dollar held steady as Middle East jitters offset softer inflation data. A MarketWatch piece noted gasoline prices rising faster than oil, pointing to the refining 'crack' spread.
- U.S. strikes Iran and Houthis threaten Saudi Arabia shipping as mediators push 10-day ceasefire
- Inflation fears are back in the spotlight as the Middle East conflict keeps oil prices elevated, analysts say
- Treasury yields are little changed as investors map geopolitical risks
4. Trump imposes 50% tariffs on Canadian goods; Dimon says he wouldn't buy stocks or Treasurys now

President Trump is imposing 50% tariffs on certain Canadian goods over alleged trade discrimination, with reporting noting a focus on Canadian autos. JPMorgan CEO Jamie Dimon said markets are underestimating risks and that he wouldn't buy stocks or Treasurys at current prices.
- Trump imposing 50% tariffs on certain Canadian goods over alleged trade discrimination
- Jamie Dimon says markets underestimate risks and he wouldn't buy stocks or Treasurys at current prices
5. Novo Nordisk sues Eli Lilly over GLP-1 comparison ads

Novo Nordisk sued Eli Lilly, alleging misleading advertising in ads that compare their GLP-1 medications. The dispute centers on marketing claims in the closely watched weight-loss and diabetes drug market.
- Novo Nordisk sues Eli Lilly over ads comparing GLP-1 medications
- Novo Nordisk sues Eli Lilly, alleging misleading GLP-1 advertising
Disclaimer: This content is for informational purposes only and is not investment advice. Investment decisions are your own responsibility.
This digest summarizes the past 24 hours of news from public RSS feeds. See the linked sources for details.
Comments
Post a Comment